{"entity":{"type":"insider","cik":"0002048497","url":"/insider/0002048497","json_url":"/insider/0002048497.json","name":"Hopman Mark","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":14,"n_filings":10,"first":"2025-06-04","last":"2026-06-25","span_basis":"filed_date"},"name_variants":[{"name":"Hopman Mark","source":"filing","n_filings":10,"first_seen":"2025-06-04","last_seen":"2026-06-25"}],"transactions":[{"id":5878084,"accession":"0002048497-26-000009","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0002048497-26-000009","line_url":"/filing/0002048497-26-000009#line-1","is_derivative":false,"issuer_cik":"0001674632","issuer_name":"Beta Bionics, Inc.","issuer_ticker":"BBNX","issuer_name_source":null,"issuer_url":"/issuer/0001674632","owner_cik":"0002048497","owner_name":"Hopman Mark","owner_display_name":"Hopman Mark","owner_url":"/insider/0002048497","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1258.0,"shares_display":"1,258","price_per_share":15.0083,"price_display":"15.01","price_state":"stated","total_value":18880.4414,"total_display":"18,880.44","total_whole":"18,880","shares_owned_after":129354.0,"shares_owned_after_display":"129,354","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-24","filed_date":"2026-06-25","scope":"insider"},{"id":6183154,"accession":"0002048497-26-000008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0002048497-26-000008","line_url":"/filing/0002048497-26-000008#line-1","is_derivative":false,"issuer_cik":"0001674632","issuer_name":"Beta Bionics, Inc.","issuer_ticker":"BBNX","issuer_name_source":null,"issuer_url":"/issuer/0001674632","owner_cik":"0002048497","owner_name":"Hopman Mark","owner_display_name":"Hopman Mark","owner_url":"/insider/0002048497","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":275.0,"shares_display":"275","price_per_share":12.31,"price_display":"12.31","price_state":"stated","total_value":3385.25,"total_display":"3,385.25","total_whole":"3,385","shares_owned_after":130612.0,"shares_owned_after_display":"130,612","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-04","filed_date":"2026-06-05","scope":"insider"},{"id":6161977,"accession":"0002048497-26-000007","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0002048497-26-000007","line_url":"/filing/0002048497-26-000007#line-1","is_derivative":false,"issuer_cik":"0001674632","issuer_name":"Beta Bionics, Inc.","issuer_ticker":"BBNX","issuer_name_source":null,"issuer_url":"/issuer/0001674632","owner_cik":"0002048497","owner_name":"Hopman Mark","owner_display_name":"Hopman Mark","owner_url":"/insider/0002048497","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5329.0,"shares_display":"5,329","price_per_share":12.6071,"price_display":"12.61","price_state":"stated","total_value":67183.2359,"total_display":"67,183.24","total_whole":"67,183","shares_owned_after":130887.0,"shares_owned_after_display":"130,887","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-02","filed_date":"2026-06-03","scope":"insider"},{"id":6233266,"accession":"0002048497-26-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0002048497-26-000002","line_url":"/filing/0002048497-26-000002#line-1","is_derivative":false,"issuer_cik":"0001674632","issuer_name":"Beta Bionics, Inc.","issuer_ticker":"BBNX","issuer_name_source":null,"issuer_url":"/issuer/0001674632","owner_cik":"0002048497","owner_name":"Hopman Mark","owner_display_name":"Hopman Mark","owner_url":"/insider/0002048497","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":353.0,"shares_display":"353","price_per_share":11.57,"price_display":"11.57","price_state":"stated","total_value":4084.21,"total_display":"4,084.21","total_whole":"4,084","shares_owned_after":139133.0,"shares_owned_after_display":"139,133","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-04","filed_date":"2026-03-05","scope":"insider"},{"id":6233263,"accession":"0002048497-26-000001","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0002048497-26-000001","line_url":"/filing/0002048497-26-000001#line-2","is_derivative":false,"issuer_cik":"0001674632","issuer_name":"Beta Bionics, Inc.","issuer_ticker":"BBNX","issuer_name_source":null,"issuer_url":"/issuer/0001674632","owner_cik":"0002048497","owner_name":"Hopman Mark","owner_display_name":"Hopman Mark","owner_url":"/insider/0002048497","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":834.0,"shares_display":"834","price_per_share":12.3616,"price_display":"12.36","price_state":"stated","total_value":10309.5744,"total_display":"10,309.57","total_whole":"10,310","shares_owned_after":139486.0,"shares_owned_after_display":"139,486","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-03","scope":"insider"},{"id":5972831,"accession":"0002048497-26-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0002048497-26-000004","line_url":"/filing/0002048497-26-000004#line-2","is_derivative":false,"issuer_cik":"0001674632","issuer_name":"Beta Bionics, Inc.","issuer_ticker":"BBNX","issuer_name_source":null,"issuer_url":"/issuer/0001674632","owner_cik":"0002048497","owner_name":"Hopman Mark","owner_display_name":"Hopman Mark","owner_url":"/insider/0002048497","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2061.0,"shares_display":"2,061","price_per_share":30.661,"price_display":"30.66","price_state":"stated","total_value":63192.321,"total_display":"63,192.32","total_whole":"63,192","shares_owned_after":136216.0,"shares_owned_after_display":"136,216","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-04","filed_date":"2026-03-16","scope":"insider"},{"id":5972827,"accession":"0002048497-26-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0002048497-26-000004","line_url":"/filing/0002048497-26-000004#line-1","is_derivative":false,"issuer_cik":"0001674632","issuer_name":"Beta Bionics, Inc.","issuer_ticker":"BBNX","issuer_name_source":null,"issuer_url":"/issuer/0001674632","owner_cik":"0002048497","owner_name":"Hopman Mark","owner_display_name":"Hopman Mark","owner_url":"/insider/0002048497","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":856.0,"shares_display":"856","price_per_share":29.3359,"price_display":"29.34","price_state":"stated","total_value":25111.5304,"total_display":"25,111.53","total_whole":"25,112","shares_owned_after":138277.0,"shares_owned_after_display":"138,277","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-02","filed_date":"2026-03-16","scope":"insider"},{"id":5194506,"accession":"0001415889-25-023899","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001415889-25-023899","line_url":"/filing/0001415889-25-023899#line-5","is_derivative":false,"issuer_cik":"0001674632","issuer_name":"Beta Bionics, Inc.","issuer_ticker":"BBNX","issuer_name_source":null,"issuer_url":"/issuer/0001674632","owner_cik":"0002048497","owner_name":"Hopman Mark","owner_display_name":"Hopman Mark","owner_url":"/insider/0002048497","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11411.0,"shares_display":"11,411","price_per_share":20.5641,"price_display":"20.56","price_state":"stated","total_value":234656.9451,"total_display":"234,656.95","total_whole":"234,657","shares_owned_after":31215.0,"shares_owned_after_display":"31,215","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-05","filed_date":"2025-09-08","scope":"insider"},{"id":5194499,"accession":"0001415889-25-023899","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-25-023899","line_url":"/filing/0001415889-25-023899#line-3","is_derivative":false,"issuer_cik":"0001674632","issuer_name":"Beta Bionics, Inc.","issuer_ticker":"BBNX","issuer_name_source":null,"issuer_url":"/issuer/0001674632","owner_cik":"0002048497","owner_name":"Hopman Mark","owner_display_name":"Hopman Mark","owner_url":"/insider/0002048497","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6818.0,"shares_display":"6,818","price_per_share":19.9736,"price_display":"19.97","price_state":"stated","total_value":136180.0048,"total_display":"136,180.00","total_whole":"136,180","shares_owned_after":31215.0,"shares_owned_after_display":"31,215","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-04","filed_date":"2025-09-08","scope":"insider"},{"id":4920644,"accession":"0001415889-25-023743","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-023743","line_url":"/filing/0001415889-25-023743#line-1","is_derivative":false,"issuer_cik":"0001674632","issuer_name":"Beta Bionics, Inc.","issuer_ticker":"BBNX","issuer_name_source":null,"issuer_url":"/issuer/0001674632","owner_cik":"0002048497","owner_name":"Hopman Mark","owner_display_name":"Hopman Mark","owner_url":"/insider/0002048497","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":848.0,"shares_display":"848","price_per_share":18.8632,"price_display":"18.86","price_state":"stated","total_value":15995.9936,"total_display":"15,995.99","total_whole":"15,996","shares_owned_after":33284.0,"shares_owned_after_display":"33,284","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-02","filed_date":"2025-09-04","scope":"insider"},{"id":5040289,"accession":"0001415889-25-022540","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-022540","line_url":"/filing/0001415889-25-022540#line-2","is_derivative":false,"issuer_cik":"0001674632","issuer_name":"Beta Bionics, Inc.","issuer_ticker":"BBNX","issuer_name_source":null,"issuer_url":"/issuer/0001674632","owner_cik":"0002048497","owner_name":"Hopman Mark","owner_display_name":"Hopman Mark","owner_url":"/insider/0002048497","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16158.0,"shares_display":"16,158","price_per_share":16.6095,"price_display":"16.61","price_state":"stated","total_value":268376.301,"total_display":"268,376.30","total_whole":"268,376","shares_owned_after":34132.0,"shares_owned_after_display":"34,132","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-19","filed_date":"2025-08-20","scope":"insider"},{"id":4245666,"accession":"0001415889-25-015670","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-25-015670","line_url":"/filing/0001415889-25-015670","is_derivative":false,"issuer_cik":"0001674632","issuer_name":"Beta Bionics, Inc.","issuer_ticker":"BBNX","issuer_name_source":null,"issuer_url":"/issuer/0001674632","owner_cik":"0002048497","owner_name":"Hopman Mark","owner_display_name":"Hopman Mark","owner_url":"/insider/0002048497","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":868.0,"shares_display":"868","price_per_share":17.89089504608295,"price_display":"17.89","price_state":"stated","total_value":15529.2969,"total_display":"15,529.30","total_whole":"15,529","shares_owned_after":34211.0,"shares_owned_after_display":"34,211","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-02","filed_date":"2025-06-04","scope":"insider","n_lines":3}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":14,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":14,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":14},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001674632","name":"Beta Bionics, Inc.","url":"/issuer/0001674632","role":"Officer (Chief Commercial Officer)","n_filings":10,"first_seen":"2025-06-04","last_seen":"2026-06-25"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0002048497","retrieved_at":"2026-08-25T08:05:35+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}